Authors

  • Soliyeva N.K., Rajabova D.Kh.

Keywords:

antiphospholipid syndrome, hemostasis, endothelial thrombocytopenia, markers,pregnancy.

References

Balogun OO, da Silva Lopes K, Ota E, Takemoto Y, Rumbold A, Takegata M, Mori R. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev. 2016 May 6;2016(5):CD004073. doi: 10.1002/14651858.CD004073.pub4. PMID: 27150280; PMCID: PMC7104220.

Demidova E.M., Voloshuk I.N., Demidov B.S., Kazaryan S.M. Primenenie normal'nyh (polivalentnyh) vnutrivennyh immunoglobulinov v klinike nevynashivaniya beremennosti. Akush i gin 2013; 6: 44-47.

de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev. 2014 Jul 4;2014(7):CD004734. doi: 10.1002/14651858.CD004734.pub4. PMID: 24995856; PMCID: PMC6769058.

Kerchelaeva S.B. The value of antibodies to phospholipids and phospholipid-binding proteins in non-developing pregnancy // Russian Bulletin of obstetrician-gynecologist. 2003. - Volume 3, No. 4. - P.11 - 16.

Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD007223. doi: 10.1002/14651858.CD007223.pub4. PMID: 28138973; PMCID: PMC6464743.

Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2020;320:1708

Polushkina E.S., SHmakov R.G. Rol' didrogesterona v privychnom nevynashivanii beremennosti. Medicinskij Sovet. 2020;(3):74-77. https://doi.org/10.21518/2079-701X-2020-3-74-77

Samigullina A.E., Kushubekova A.K. Analiz chastoty i struktury nevynashivaniya beremennosti // Sovremennye problemy nauki i obrazovaniya. – 2018. – № 6.;

Solieva N.K., Tuksonova D. I., Bobokulova S.B. The role of determining the study of D- Dimer parameters in predicting dic syndrome in women withantenatel fetal death// Аcademicia an international multidisciplinary research journal. - 2020. - №7. - P. 582-584.

Stirrat GM. Recurrent miscarriage. Lancet. 2010; 336: 673-5.CAS Article PubMed Google Scholar

Solieva N.K., Negmatullaeva M.N, Sultonova N.A. Features Of The Anamnesis Of Women With The Threat Of Miscarriage And Their Role In Determining The Risk Group// The American Journal of Medical Sciences and Pharmaceutical Research. - 2020. - № 2(09). - P. 32-34.

Schleussner E., Kamin G., Seliger G., Rogenhofer N., Ebner S., Toth B., Schenk M., Henes M., Bohlmann MK., Fischer T., Brosteanu O., Bauersachs R., Petroff D., ETHIG II group. Low-molecular-weight heparin for women with unexplained reccurent pregnancy loss: a multicentertrial with a minimization randomization scheme// Ann Inter Med. 2015 May 5;162(9): 601-9

Tuksanova Dilbar Ismatovna and Solieva Nozima Karimovna. The value of the immune status in miscarriage // Evropean Journal Of Pharmaceutical and Medical Research. - 2020. - №7 (6). - P. 117- 119.

Volgsten H, Jansson C, Darj E, Stavreus-Evers A. Women's experiences of miscarriage related to diagnosis, duration, and type of treatment. Acta Obstet Gynecol Scand. 2018 Dec;97(12):1491-1498. doi: 10.1111/aogs.13432. Epub 2018 Sep 21. PMID: 30063247.

Wahabi HA, Fayed AA, Esmaeil SA, Bahkali KH. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. 2018 Aug 6;8(8):CD005943. doi: 10.1002/14651858.CD005943.pub5. PMID: 30081430; PMCID: PMC6513446.

Yuksel H., Kayatas S., Boza AT., Api M., Ertekin AA., Cam C. Low molecular weight heparin use unexplained recurent miscarriage// Pak J Med Sci. 2014 Nov-Dec. 30(6)., 1232-7.

Zaripova D. and Sharipova R. Comparative evaluation of the use of aleandronic acid in menopausal women complicated by osteoporosis. European journal of biomedical and pharmaceutical sciences. 2020.Vol-7, issue-CAS Article PubMed Google Scholar

Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis. PLoS One. 2017 Apr 17;12(4):e0175708. doi: 10.1371/journal.pone.0175708. PMID: 28414788; PMCID: PMC5393567.